Results indicated huLuc63-c11D5.3 Short CAR-T cells killed CS1+ tumor cells more rapidly than BCMA+ targets (Supplementary Fig. 15), which is consistent with previous observations (Fig. 2d) and argues against the hypothesis that OR-gate CAR-T cells were less effective against the CS1 antigen. Here, TNFRSF17 is linked to neoplasm.